Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III)

被引:221
作者
Rohrmann, S
Smit, E
Giovannucci, E
Platz, EA
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
[2] SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA
[3] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA
[4] Harvard Univ, Sch Med, Boston, MA USA
[5] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA
[6] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[7] Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA
关键词
NHANES III; lower urinary tract symptoms; metabolic syndrome; glycosylated hemoglobin; elderly men;
D O I
10.1038/sj.ijo.0802881
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: To examine the association of components of the metabolic syndrome with lower urinary tract symptoms (LUTS), which often result from prostate enlargement and heightened tone of prostate and bladder smooth muscle. DESIGN: Third National Health and Examination Survey (NHANES III), from which LUTS cases and controls were selected. SUBJECTS: A total of 2372 men aged 60 + y who participated in NHANES III. LUTS cases were men with at least three of these four symptoms: nocturia, incomplete bladder emptying, weak stream, and hesitancy, and who never had noncancer prostate surgery. Controls were men without any of the symptoms and who never had noncancer prostate surgery. MEASUREMENTS: As part of NHANES III, an oral glucose tolerance test was carried out, glycosylated hemoglobin, HDL and LDL cholesterol, and triglycerides were measured, and history of diabetes mellitus and hypertension were assessed. Logistic regression was used to calculate odds ratios (ORs) after applying sampling weights. RESULTS: History of diabetes (OR 1.67; 95% confidence interval (CI) 0.72-3.86) and hypertension (OR 1.76; 95% CI 1.20-2.59) appeared to be positively associated with LUTS. The odds of LUTS increased with increasing glycosylated hemoglobin (P-trend = 0.005). No statistically significant associations between fasting or 2-h glucose or fasting insulin and LUTS were observed. However, men classified as having three or more components of the metabolic syndrome had an increased odds of LUTS (OR 1.80; 95% CI 1.11-2.94). CONCLUSION: These findings support the role for metabolic perturbations in the etiology of LUTS.
引用
收藏
页码:310 / 316
页数:7
相关论文
共 33 条
[1]   Sex steroid hormones, upper body obesity, and insulin resistance [J].
Abate, N ;
Haffner, SM ;
Garg, A ;
Peshock, RM ;
Grundy, SM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (10) :4522-4527
[2]   Storage and voiding symptoms: Pathophysiologic aspects [J].
Andersson, KE .
UROLOGY, 2003, 62 (5B) :3-10
[3]  
[Anonymous], 1997, SOFTWARE STAT ANAL C
[4]  
[Anonymous], 1994, VITAL HLTH STAT, V1, P1
[5]   THE AMERICAN-UROLOGICAL-ASSOCIATION SYMPTOM INDEX FOR BENIGN PROSTATIC HYPERPLASIA [J].
BARRY, MJ ;
FOWLER, FJ ;
OLEARY, MP ;
BRUSKEWITZ, RC ;
HOLTGREWE, HL ;
MEBUST, WK ;
COCKETT, ATK ;
BLAIVAS, JG ;
WEIN, AJ .
JOURNAL OF UROLOGY, 1992, 148 (05) :1549-1557
[6]   Body mass index and the prevalence of hypertension and dyslipidemia [J].
Brown, CD ;
Higgins, M ;
Donato, KA ;
Rohde, FC ;
Garrison, R ;
Obarzanek, E ;
Ernst, ND ;
Horan, M .
OBESITY RESEARCH, 2000, 8 (09) :605-619
[7]   Insulin-like growth factors and risk of benign prostatic hyperplasia [J].
Chokkalingam, AP ;
Gao, YT ;
Deng, J ;
Stanczyk, FZ ;
Sesterhenn, IA ;
Mostofi, FK ;
Fraumeni, JF ;
Hsing, AW .
PROSTATE, 2002, 52 (02) :98-105
[8]   Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia [J].
Dahle, SE ;
Chokkalingam, AP ;
Gao, YT ;
Deng, J ;
Stanczyk, FZ ;
Hsing, AW .
JOURNAL OF UROLOGY, 2002, 168 (02) :599-604
[9]  
*FOOD DRUG ADM, EL OR BOOK APPR DRUG
[10]   A PROSPECTIVE-STUDY OF PLASMA-HORMONE LEVELS, NONHORMONAL FACTORS, AND DEVELOPMENT OF BENIGN PROSTATIC HYPERPLASIA [J].
GANN, PH ;
HENNEKENS, CH ;
LONGCOPE, C ;
VERHOEKOFTEDAHL, W ;
GRODSTEIN, F ;
STAMPFER, MJ .
PROSTATE, 1995, 26 (01) :40-49